DB06108InvestigationalGene Therapies
Investigated for use/treatment in colorectal cancer.
- Primary indication
- Investigated for use/treatment in colorectal cancer.Curator reviewed
- Also known as
- modified Ankara virus-mediated suicide gene delivery vector TG4023 · MVA-FCU1
- Code names
- TG-4023
What you can answer from here — as of August 16, 2024
Which companies are running trials of TG4023, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account